Euclises
Euclises is headquartered in United States and has $2.2M in recorded funding across 2 rounds.
- Website
- euclises.com
- Total Funding
- $2.2M
- Last Round
- $2.0M Series AApr 2015
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.
About
Euclises Pharmaceuticals is a drug discovery and development company creating next-generation cancer and pain therapies that block tumor immune evasion.
Summary
Euclises is a Biotech company based in United States. It has raised $2.2M in total across 2 rounds, most recently a $2.0M Series A round in Apr 2015. Investors include Cultivation Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2015
Sign up to see all 2 events
Funding: Angel through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/euclises"><img src="https://indexed.vc/api/badge/company/euclises" alt="Euclises on Indexed.vc" width="260" height="76" /></a>